⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for advanced head and neck squamous cell carcinoma

Every month we try and update this database with for advanced head and neck squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801
Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaNCT03254927
Advanced Head a...
CDX-3379 and ce...
18 Years - Celldex Therapeutics
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT04533750
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT04533750
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Quad Shot Radiotherapy in Combination With Immune Checkpoint InhibitionNCT04454489
Advanced Head a...
Recurrent Head ...
Metastatic Head...
Stage III Cutan...
Locally Advance...
Stage IV Cutane...
Pembrolizumab (...
Quad-shot palli...
18 Years - Wake Forest University Health Sciences
Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck CancerNCT05050162
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oropha...
Squamous Cell C...
Cisplatin
Cisplatin
Quality-of-Life...
Questionnaire A...
Radiation Thera...
18 Years - NRG Oncology
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801
Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center
Influencing Factors for Physical Activity in People With Head and Neck CancerNCT06272513
Advanced Head a...
18 Years - Kantonsspital Winterthur KSW
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCCNCT05057247
Squamous Cell C...
Recurrent Squam...
Metastatic Head...
Advanced Head a...
Advanced Head a...
Duvelisib
Docetaxel
18 Years - Dana-Farber Cancer Institute
PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell CarcinomaNCT05743777
Advanced Head a...
Pembrolizumab
MET-4
Placebo
18 Years - Canadian Cancer Trials Group
Quad Shot Radiotherapy in Combination With Immune Checkpoint InhibitionNCT04454489
Advanced Head a...
Recurrent Head ...
Metastatic Head...
Stage III Cutan...
Locally Advance...
Stage IV Cutane...
Pembrolizumab (...
Quad-shot palli...
18 Years - Wake Forest University Health Sciences
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801
Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center
Influencing Factors for Physical Activity in People With Head and Neck CancerNCT06272513
Advanced Head a...
18 Years - Kantonsspital Winterthur KSW
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: